History

• 2016

  Chung Mei Biopharma Co., Ltd was founded.

• 2017
  Jan

  Signed technology transfer and license agreement of “Zhaohe Cao-based botanical drug DCB-BO1301” with Development Center for Biotechonology(DCB).

  1. 
• Mar

  Received IND NO. 133599 approval from USFDA.

• Jun

  Invited by Botanical Drug Development Consortium to participate in “BioTaiwan 2017”.

  1. 
• Aug

  Participated in “Wow! Taiwan Selects 2017” marketing exhibition in Malaysia.

  1. 
• 2018
  Apr

  Participated in “The Malaysia International Halal Showcase 2018”.

  1. 
• May

  Launched K21 Probiotic in Myanmar market.

  1. 
• Jun

  To expand Asian market, launched OTC medicine and health food to Macau

• Jul

  Participated in “BioTaiwan 2018”.

  1. 
• Aug

  OTC medicine and health food products launched in HK.

• Sep

  Participated in “Vitafoods Asia 2018”.

  1. 
• 2019

  To expand ASEAN markets, launched health food in Singapore.

• 2020

  Continued to actively expand business in ASEAN markets, launched health food in Thailand and the Philippines.

• 2021

  To expand health food business to online store channel in China.